Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Brain Renin–Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity
Authors
Keywords
AT<sub>1</sub>-R, Methamphetamine, Angiotensin II, D3R, Hyperlocomotion, Neurotoxicity.
Journal
Neurotherapeutics
Volume 15, Issue 2, Pages 500-510
Publisher
Springer Nature
Online
2018-02-21
DOI
10.1007/s13311-018-0613-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Asiatic acid attenuates methamphetamine-induced neuroinflammation and neurotoxicity through blocking of NF-kB/STAT3/ERK and mitochondria-mediated apoptosis pathway
- (2017) Ji-Hyun Park et al. Journal of Neuroinflammation
- Structural basis for selectivity and diversity in angiotensin II receptors
- (2017) Haitao Zhang et al. NATURE
- Beneficial effects of Angiotensin II receptor blockers in brain disorders
- (2017) J.M. Saavedra PHARMACOLOGICAL RESEARCH
- Amphetamine-related drugs neurotoxicity in humans and in experimental animals: Main mechanisms
- (2017) Rosario Moratalla et al. PROGRESS IN NEUROBIOLOGY
- Angiotensin II Causes Apoptosis of Adult Hippocampal Neural Stem Cells and Memory Impairment Through the Action on AMPK-PGC1α Signaling in Heart Failure
- (2017) Min-Seok Kim et al. Stem Cells Translational Medicine
- Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users
- (2016) M Kohno et al. MOLECULAR PSYCHIATRY
- Synaptic mechanisms underlying persistent cocaine craving
- (2016) Marina E. Wolf NATURE REVIEWS NEUROSCIENCE
- Chronic methamphetamine self-administration disrupts cortical control of cognition
- (2016) Aurelien Bernheim et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Melatonin Protects SH-SY5Y Neuronal Cells Against Methamphetamine-Induced Endoplasmic Reticulum Stress and Apoptotic Cell Death
- (2016) Pawaris Wongprayoon et al. NEUROTOXICITY RESEARCH
- Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
- (2016) Patrick Gavin Kehoe et al. Alzheimers Research & Therapy
- Correction: Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses
- (2016) PLOS MEDICINE
- The Implications of Angiotensin-Converting Enzymes and Their Modulators in Neurodegenerative Disorders: Current and Future Perspectives
- (2015) Parneet Kaur et al. ACS Chemical Neuroscience
- Caveolin-1 prevents sustained angiotensin II-induced resistance artery constriction and obesity-induced high blood pressure
- (2015) Istvan Czikora et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Dopamine D2 and angiotensin II type 1 receptors form functional heteromers in rat striatum
- (2015) E. Martínez-Pinilla et al. BIOCHEMICAL PHARMACOLOGY
- The Brain on Drugs: From Reward to Addiction
- (2015) Nora D. Volkow et al. CELL
- Arginine Methyltransferase 1 in the Nucleus Accumbens Regulates Behavioral Effects of Cocaine
- (2015) Y. Li et al. JOURNAL OF NEUROSCIENCE
- A previous history of repeated amphetamine exposure modifies brain angiotensin II AT1 receptor functionality
- (2015) B.S. Casarsa et al. NEUROSCIENCE
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
- (2015) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration
- (2015) Carmen Diaz-Ruiz et al. Oncotarget
- Dopamine D3 Receptor Is Necessary for Ethanol Consumption: An Approach with Buspirone
- (2014) Gian Marco Leggio et al. NEUROPSYCHOPHARMACOLOGY
- Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [3H]dopamine and [3H]norepinephrine release
- (2013) Vidya Narayanaswami et al. BIOCHEMICAL PHARMACOLOGY
- The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism
- (2013) Patricia K. Sonsalla et al. EXPERIMENTAL NEUROLOGY
- Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA
- (2013) Antonio Dominguez-Meijide et al. NEUROPHARMACOLOGY
- Molecular characterization of individual D3 dopamine receptor-expressing cells isolated from multiple brain regions of a novel mouse model
- (2012) Ying Li et al. Brain Structure & Function
- Prevention of methamphetamine-induced microglial cell death by TNF-α and IL-6 through activation of the JAK-STAT pathway
- (2012) Vanessa Coelho-Santos et al. Journal of Neuroinflammation
- Dopaminergic neuroprotection of hormonal replacement therapy in young and aged menopausal rats: role of the brain angiotensin system
- (2011) A. I. Rodriguez-Perez et al. BRAIN
- Neuroprotective Effect of Resveratrol Against Methamphetamine-Induced Dopaminergic Apoptotic Cell Death in a Cell Culture Model of Neurotoxicity
- (2011) Kavin Kanthasamy et al. Current Neuropharmacology
- Binding of Losartan to Angiotensin AT1 Receptors Increases Dopamine D1 Receptor Activation
- (2011) D. Li et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The projected effect of risk factor reduction on Alzheimer's disease prevalence
- (2011) Deborah E Barnes et al. LANCET NEUROLOGY
- Brain renin-angiotensin—A new look at an old system
- (2011) John W. Wright et al. PROGRESS IN NEUROBIOLOGY
- Striatal dopamine D1 and D2 receptors: Widespread influences on methamphetamine-induced dopamine and serotonin neurotoxicity
- (2011) Noah B. Gross et al. SYNAPSE
- The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access
- (2010) Laura Orio et al. ADDICTION BIOLOGY
- Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders
- (2010) Christian A. Heidbreder et al. Annals of the New York Academy of Sciences
- The AT1 angiotensin II receptor blockade attenuates the development of amphetamine-induced behavioral sensitization in a two-injection protocol
- (2010) Maria Constanza Paz et al. SYNAPSE
- Renin–Angiotensin System Blockade and Cardiovascular and Renal Protection
- (2009) Byron J. Hoogwerf AMERICAN JOURNAL OF CARDIOLOGY
- Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function
- (2009) Chiara Fiorentini et al. CURRENT OPINION IN PHARMACOLOGY
- Striatal Dopamine D2/D3 Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity
- (2009) B. Lee et al. JOURNAL OF NEUROSCIENCE
- Telmisartan for Prevention of Cardiovascular Events
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin-Converting Enzyme 2 Overexpression in the Subfornical Organ Prevents the Angiotensin II–Mediated Pressor and Drinking Responses and Is Associated With Angiotensin II Type 1 Receptor Downregulation
- (2008) Yumei Feng et al. CIRCULATION RESEARCH
- Ang II and Ang IV: Unraveling the Mechanism of Action on Synaptic Plasticity, Memory, and Epilepsy
- (2008) Dimitri De Bundel et al. CNS Neuroscience & Therapeutics
- Effect of angiotensin-related antihypertensives on brain neurotransmitter levels in rats
- (2008) Trisha A. Jenkins NEUROSCIENCE LETTERS
- Monoamine transporters and psychostimulant addiction
- (2007) Leonard L. Howell et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started